These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6352621)

  • 21. [Clinical studies of ceftazidime in the pediatric field].
    Hoshina H; Mikuni K; Ichihashi H
    Jpn J Antibiot; 1984 Mar; 37(3):460-8. PubMed ID: 6376855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative study on bacterial eradication rate and clinical efficacy of CDTR, CFPN, and FRPM for treatment of children with otitis media and lower respiratory tract infection due to Streptococcus pneumoniae and Haemophilus influenzae].
    Sakata H
    Jpn J Antibiot; 2001 May; 54 Suppl B():96. PubMed ID: 12638154
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical results and pharmacokinetics of ceftazidime treatment in patients with cystic fibrosis.
    Strandvik B; Malmborg AS; Alfredson H; Ericsson A
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():283-7. PubMed ID: 6352633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Haemophilus influenzae.
    Gordon A
    Scott Med J; 1974 Nov; 19(6):251-2. PubMed ID: 4547856
    [No Abstract]   [Full Text] [Related]  

  • 25. Ceftazidime in the treatment of complicated respiratory and urinary tract infections.
    Loebis LH; Williams KJ
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():59-64. PubMed ID: 6352656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Value of quantitative bacteriological examination of sputum in the evaluation of the effectiveness of chemotherapy of bacterial respiratory tract infections. I. Bacteriological studies].
    Przybyłkiewicz Z; Nikodemowicz E; Kasprowicz A; Owsiński J
    Pneumonol Pol; 1980 Aug; 48(8):535-43. PubMed ID: 6775309
    [No Abstract]   [Full Text] [Related]  

  • 27. Cefoperazone in lower respiratory tract infections.
    Woods CJ; Ellis-Pegler RB
    Drugs; 1981; 22 Suppl 1():96-9. PubMed ID: 6456897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ceftazidime treatment in intensive care patients.
    van Dalen R; Muytjens HL; Gimbrère JS
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():189-97. PubMed ID: 6225763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ceftazidime in clinical practice.
    Alestig K; Eilard T; Norrby R; Svensson R; Trollfors B; Brorson JE
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():111-4. PubMed ID: 6225759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meropenem compared with ceftazidime in the empiric treatment of acute severe infections in hospitalized children. Italian Pediatric Meropenem Study Group.
    Principi N; Marchisio P
    J Chemother; 1998 Apr; 10(2):108-13. PubMed ID: 9603635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiological Features and Antibiotic Resistance Patterns of Haemophilus influenzae Originating from Respiratory Tract and Vaginal Specimens in Pediatric Patients.
    Li JP; Hua CZ; Sun LY; Wang HJ; Chen ZM; Shang SQ
    J Pediatr Adolesc Gynecol; 2017 Dec; 30(6):626-631. PubMed ID: 28629795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ceftazidime in patients with Pseudomonas infections.
    Eron LJ; Park CH; Hixon DL; Goldenberg RI; Poretz DM
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():161-9. PubMed ID: 6225762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An open study of the use of ceftazidime in Gram-negative infections.
    Wardle JK; Snow MH; Ingham HR; Selkon JB
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():389-93. PubMed ID: 6352650
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of ceftazidime in the treatment of severe localized and systemic infections.
    Gabrielli GB; Corrocher R; De Sandre G
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):167-9. PubMed ID: 6370875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapy of chronic recurrent respiratory tract infections].
    Nagatake T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Mar; 27(3):289-92. PubMed ID: 2615085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacokinetics and clinical evaluation of cefpirome in children].
    Ihara T; Kamiya H; Ito M; Sakurai M
    Jpn J Antibiot; 1991 Feb; 44(2):207-12. PubMed ID: 2041160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Use of Runac in patients with infections of the lower respiratory tract].
    Popovac D; Plavsić Z; Filipović M
    Plucne Bolesti; 1990; 42(3-4):188-90. PubMed ID: 2101948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical characteristics of beta-lactamase negative ampicillin resistant Haemophilus influenzae (BLNAR) in respiratory tract].
    Ikeda T; Oishi K; Nagatake T; Yoshida T
    Nihon Rinsho; 2001 Apr; 59(4):745-9. PubMed ID: 11305000
    [No Abstract]   [Full Text] [Related]  

  • 39. Ceftazidime treatment of chronic Pseudomonas aeruginosa respiratory tract infection in cystic fibrosis.
    Permin H; Koch C; Høiby N; Christensen HO; Møller AF; Møller S
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():313-23. PubMed ID: 6352636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Haemophilus influenzae infection].
    Kurosaki T
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():418-22. PubMed ID: 12722254
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.